Atrial Fibrillation

A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Multi-National Study For Evaluation Of Efficacy And Safety Of Du-176b Versus Warfarin In Subjects With Atrial Fibrillation – Effective Anticoagulation With Factor Xa Next Generation In Atrial Fibrillation.

Register Today!

Trial Information

Trial Duration6 years
Number of Visits60-72
Lead CRCJessica Richer

For additional information
on this trial contact: